Edition:
United Kingdom

Five Prime Therapeutics Inc (FPRX.OQ)

FPRX.OQ on NASDAQ Stock Exchange Global Select Market

10.04USD
16 Jan 2019
Change (% chg)

-- (--)
Prev Close
$10.04
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
131,529
52-wk High
$22.81
52-wk Low
$7.84

Chart for

About

Five Prime Therapeutics, Inc. is a clinical-stage biotechnology company focused on discovering and developing protein therapeutics. The Company's product candidates include Cabiralizumab (FPA008), which is an antibody that inhibits colony stimulating factor-1 receptor, that it is studying in clinical trials as a monotherapy in... (more)

Overall

Beta: 4.21
Market Cap(Mil.): $1,122.56
Shares Outstanding(Mil.): 28.90
Dividend: --
Yield (%): --

Financials

  FPRX.OQ Industry Sector
P/E (TTM): -- 69.71 34.38
EPS (TTM): -4.24 -- --
ROI: -29.38 8.99 14.96
ROE: -31.27 10.13 16.53

Earnings vs. Estimates